Tarsus Pharmaceuticals, Inc.
TARS · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 4 ·
Latest disclosures
-
Pyott David E I: Form 4
Insider disclosure · Filed · Report period 15 Sep 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- TARS · 87650L103 - Common Stock
Company details and SEC sources
CIK 0001819790 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- TARS on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 15440 Laguna Canyon Road, Irvine, CA, 92618
- Incorporated in
- DE
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields